Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Shin Maeda, Kota Tsuruya et al.|Hepatology Research|2021Cited by 50
Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of HepatologyNahoko Kikuchi, Wasaburo Koizumi, Haruki Uojima et al.|Hepatology Research|2021Cited by 24
A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinomaShuichiro Iwasaki, Wasaburo Koizumi, Hisashi Hidaka et al.|Clinical Journal of Gastroenterology|2021Cited by 14
A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case reportHaruki Uojima, Wasaburo Koizumi, Hisashi Hidaka et al.|Journal of Medical Case Reports|2019Cited by 13
Risk factors for loss of skeletal muscle mass in patients with cirrhosisJi Hyun Sung, Wasaburo Koizumi, Haruki Uojima et al.|Hepatology Research|2019Cited by 11